A detailed history of Intrinsic Edge Capital Management LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 254,411 shares of CSTL stock, worth $8.59 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
254,411
Previous 223,567 13.8%
Holding current value
$8.59 Million
Previous $4.95 Million 11.83%
% of portfolio
0.53%
Previous 0.4%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $581,100 - $769,249
30,844 Added 13.8%
254,411 $5.54 Million
Q1 2024

May 14, 2024

SELL
$18.06 - $25.3 $1.85 Million - $2.6 Million
-102,703 Reduced 31.48%
223,567 $4.95 Million
Q4 2023

Feb 14, 2024

BUY
$12.19 - $22.43 $2.07 Million - $3.81 Million
170,000 Added 108.79%
326,270 $7.04 Million
Q3 2023

Nov 14, 2023

SELL
$13.28 - $20.3 $2.66 Million - $4.06 Million
-199,936 Reduced 56.13%
156,270 $2.64 Million
Q2 2023

Aug 14, 2023

SELL
$11.66 - $26.0 $462,085 - $1.03 Million
-39,630 Reduced 10.01%
356,206 $4.89 Million
Q1 2023

May 15, 2023

BUY
$19.47 - $28.49 $601,019 - $879,457
30,869 Added 8.46%
395,836 $8.99 Million
Q4 2022

Feb 14, 2023

BUY
$18.08 - $30.0 $950,411 - $1.58 Million
52,567 Added 16.83%
364,967 $8.59 Million
Q3 2022

Nov 14, 2022

BUY
$22.51 - $34.32 $675,300 - $1.03 Million
30,000 Added 10.62%
312,400 $8.15 Million
Q2 2022

Aug 15, 2022

BUY
$16.0 - $45.99 $1.12 Million - $3.22 Million
70,000 Added 32.96%
282,400 $6.2 Million
Q1 2022

May 16, 2022

BUY
$33.17 - $46.98 $7.05 Million - $9.98 Million
212,400 New
212,400 $9.53 Million
Q4 2021

Feb 14, 2022

SELL
$39.06 - $67.58 $5.78 Million - $9.99 Million
-147,895 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$60.13 - $77.6 $1.33 Million - $1.71 Million
-22,070 Reduced 12.99%
147,895 $9.84 Million
Q2 2021

Aug 16, 2021

BUY
$50.07 - $76.78 $6.51 Million - $9.98 Million
129,965 Added 324.91%
169,965 $12.5 Million
Q1 2021

May 17, 2021

BUY
$58.92 - $97.33 $2.36 Million - $3.89 Million
40,000 New
40,000 $2.74 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $888M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Intrinsic Edge Capital Management LLC Portfolio

Follow Intrinsic Edge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.